| 
								          							Medical Waste Management Plan
<br />      						Kaiser Permanente — Lathrop Medical Office
<br />       								1/01/2023-12/31/2023
<br />   						(b)Exposure to chemical sanitizer by rinsing with, or immersion in,one of the
<br />   						following for a minimum of three minutes:
<br />      						(1) Hypochlorite solution(500 ppm available chlorine).
<br />      						(2) Phenolic solution(500 ppm active agent).
<br />      						(3)Iodoform solution(100 ppm available iodine).
<br />      						(4)Quaternary ammonium solution(400 ppm active agent).
<br />      						(5)Pure Chlorine(500 ppm),Dilution of 5m1 in 100 ml of water.
<br />      						(6)Oxycide(Peroxyacetic Acid/Hydrogen Peroxide)Concentrate
<br />     	The following materials are classified as medical waste:    Container Requirements and Labeling Procedures:
<br />     	Sharps Waste-a device that has acute rigid corners,edges,or protuberances capable
<br />     	of cutting or piercing,including,but not limited to,hypodermic needles,hypodermic       Shall be contained in a United States Food and Drug Administration(USFDA)
<br />     	needles with syringes,blades,needles with attached tubing,acupuncture needles,root   approved sharps container that meets USFDA labeling requirements and is
<br />     	canal files,broken glass items used in health care such as Pasteur pipettes and blood    handled pursuant to Section 118235."Sharps Waste",or the Biohazard symbol
<br />     	vials contaminated with biohazardous waste,and any item capable of cutting or  	and the word"BIOHAZARD"
<br />     	piercing from trauma scene waste.
<br />     	Biohazardous Waste—Regulated medical waste,clinical waste,or biomedical waste
<br />     	that is a waste or reusable material derived from the medical treatment of a human,
<br />     	which includes diagnosis and immunization;or from biomedical research,which
<br />     	includes the production and testing of biological products.
<br />     	Regulated medical waste or clinical waste or biomedical waste suspected of containing
<br />     	a highly communicable disease.
<br />     	Laboratory waste such as human specimen cultures;cultures and stocks of infectious
<br />     	agents from research;wastes from the production of bacteria,viruses,spores,   	Shall be placed in a biohazard bag conspicuously labeled with the words
<br />     	discarded live and attenuated vaccines used in human health care or research,  	"Biohazardous Waste"or with the international biohazard symbol and the word
<br />     	including Brucellosis and Contagious Ecthyma,as defined by the department;culture     "BIOHAZARD."
<br />     	dishes,devices used to transfer,inoculate,and mix cultures;and wastes identified by     Containers may be of any color and shall be labeled with the words
<br />     	Section 173.134 of Title 49 of the Code of Federal Regulations as Category B"once      "Biohazardous Waste"or with the international biohazard symbol and the word
<br />     	wasted"for laboratory wastes.      						"BIOHAZARD"on the lid and on the sides so as to be visible from any lateral
<br />     	Waste that,at the point of transport from the generator's site or at the point of disposal    direction.
<br />     	contains recognizable fluid human blood,fluid human blood products,containers,or
<br />     	equipment containing human blood that is fluid.
<br />     	Waste containing discarded materials contaminated with excretion,exudate,or
<br />     	secretions from humans that are required to be isolated by the infection control staff,
<br />     	the attending physician and surgeon,or the local health officer,to protect others from
<br />     	highly communicable diseases or diseases of animals that are communicable to
<br />     	humans.
<br />     	Non-RCRA Pharmaceutical wastes—waste pharmaceuticals which are not federally    A person may consolidate into a common container,which may be reusable,
<br />     	hazardous(non-RCRA),radioactive or classified as municipal solid waste(trash).	sharps waste,as defined in Section 117755,and pharmaceutical wastes,as
<br />     	*Pharmaceutical waste classified by the federal Drug Enforcement Agency(DEA)as     defined in Section 117747.The container shall be labeled with the biohazardous
<br />     	"controlled substances"are disposed in compliance with DEA requirements.     	waste symbol and the words"HIGH HEAT ONLY,""INCINERATION,"or other
<br />      											label approved by the department on the lid and on the sides,so as to be visible
<br />      											from any lateral direction.
<br />    			(b) Storage area description with storage methods utilized,including duration and
<br /> 				temperature,if applicable.
<br />   				r   Interim Storage Area:
<br />      				•   Medical waste that is stored in an area prior to transfer to the designated
<br />   					accumulation area, as defined in Section 118310.
<br />      				•   Shall be stored in an area that is either locked or under direction supervision or
<br />   					surveillance.
<br />      				•   Intermediate storage areas shall be marked with the international biohazard symbol or
<br />   					the signage described in Section 1183 10.
<br />      				•   These warning signs shall be readily legible from a distance of five feet.
<br />      				•   This section does not apply to the rooms in which medical waste is generated.
<br />
								 |